Detalles de la búsqueda
1.
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer.
Lung Cancer
; 146: 78-85, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32521388
Resultados
1 -
1
de 1
1
Próxima >
>>